217 related articles for article (PubMed ID: 29332907)
1. Patients' Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From Kochi RYOMA Study.
Kubo T; Hirota T; Baba Y; Ochi Y; Takahashi A; Yamasaki N; Hamashige N; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
Circ J; 2018 Feb; 82(3):824-830. PubMed ID: 29332907
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Results from Kochi RYOMA Study.
Kubo T; Kitaoka H; Okawa M; Hirota T; Hayato K; Yamasaki N; Matsumura Y; Yabe T; Takata J; Doi YL
Circ J; 2009 Sep; 73(9):1599-605. PubMed ID: 19590139
[TBL] [Abstract][Full Text] [Related]
3. Clinical Profile of Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From Kochi RYOMA Study.
Hirota T; Kubo T; Baba Y; Ochi Y; Takahashi A; Yamasaki N; Hamashige N; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
Circ J; 2019 Jul; 83(8):1747-1754. PubMed ID: 31257313
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features of Heart Failure in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.
Miyamoto Y; Kubo T; Ochi Y; Baba Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
Circ J; 2022 Nov; 86(12):1934-1940. PubMed ID: 35675987
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
[TBL] [Abstract][Full Text] [Related]
6. Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study.
Kubo T; Kitaoka H; Okawa M; Hirota T; Hayato K; Yamasaki N; Matsumura Y; Yabe T; Doi YL
J Cardiol; 2010 Nov; 56(3):314-9. PubMed ID: 20719473
[TBL] [Abstract][Full Text] [Related]
7. Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.
Kubo T; Baba Y; Ochi Y; Takahashi A; Hirota T; Yamasaki N; Hamashige N; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
Circ Rep; 2020 Jul; 2(8):433-439. PubMed ID: 33693265
[No Abstract] [Full Text] [Related]
8. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry.
Gimeno JR; Olivotto I; Rodríguez AI; Ho CY; Fernández A; Quiroga A; Espinosa MA; Gómez-González C; Robledo M; Tojal-Sierra L; Day SM; Owens A; Barriales-Villa R; Larrañaga JM; Rodríguez-Palomares J; González-Del-Hoyo M; Piqueras-Flores J; Reza N; Chumakova O; Ashley EA; Parikh V; Wheeler M; Jacoby D; Pereira AC; Saberi S; Helms AS; Villacorta E; Gallego-Delgado M; de Castro D; Domínguez F; Ripoll-Vera T; Zorio-Grima E; Sánchez-Martínez JC; García-Álvarez A; Arbelo E; Mogollón MV; Fuentes-Cañamero ME; Grande E; Peña C; Monserrat L; Lakdawala NK;
ESC Heart Fail; 2022 Aug; 9(4):2189-2198. PubMed ID: 36255281
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic cardiomyopathy in the elderly.
Kubo T; Kitaoka H; Okawa M; Nishinaga M; Doi YL
Geriatr Gerontol Int; 2010 Jan; 10(1):9-16. PubMed ID: 20102377
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Long-Term Outcomes of Hypertrophic Cardiomyopathy.
Yoshinaga M; Yoshikawa D; Ishii H; Hirashiki A; Okumura T; Kubota A; Sakai S; Harada K; Somura F; Mizuno T; Fujiwara W; Yokoi H; Hayashi M; Ishii J; Ozaki Y; Murohara T; Yoshida Y; Amano T; Izawa H
Int Heart J; 2015; 56(4):415-20. PubMed ID: 26084460
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.
Goto D; Kinugawa S; Hamaguchi S; Sakakibara M; Tsuchihashi-Makaya M; Yokota T; Yamada S; Yokoshiki H; Tsutsui H;
J Cardiol; 2013 Jan; 61(1):65-70. PubMed ID: 23078864
[TBL] [Abstract][Full Text] [Related]
12. [Clinical course of hypertrophic cardiomyopathy in a non selected population. The Experience of the Italian Multicenter Cardiomyopathy Study].
Cecchi F; Olivotto I; Lazzeroni E; Chiriatti G; Sachero A; Beretta L; Giagnoni E; Renosto G; Montereggi A; Baldassarre S; Castelli G; Ciaccheri M
G Ital Cardiol; 1997 Nov; 27(11):1133-43. PubMed ID: 9463057
[TBL] [Abstract][Full Text] [Related]
13. Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
Kitaoka H; Kubo T; Hayashi K; Yamasaki N; Matsumura Y; Furuno T; Doi YL
Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):544-9. PubMed ID: 23060455
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
Marstrand P; Han L; Day SM; Olivotto I; Ashley EA; Michels M; Pereira AC; Wittekind SG; Helms A; Saberi S; Jacoby D; Ware JS; Colan SD; Semsarian C; Ingles J; Lakdawala NK; Ho CY;
Circulation; 2020 Apr; 141(17):1371-1383. PubMed ID: 32228044
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
[TBL] [Abstract][Full Text] [Related]
16. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Maron BJ; Casey SA; Poliac LC; Gohman TE; Almquist AK; Aeppli DM
JAMA; 1999 Feb; 281(7):650-5. PubMed ID: 10029128
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular remodeling of hypertrophic cardiomyopathy: longitudinal observation in rural community.
Kitaoka H; Kubo T; Okawa M; Hitomi N; Furuno T; Doi YL
Circ J; 2006 Dec; 70(12):1543-9. PubMed ID: 17127796
[TBL] [Abstract][Full Text] [Related]
18. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
[TBL] [Abstract][Full Text] [Related]
19. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.
Olivotto I; Cecchi F; Casey SA; Dolara A; Traverse JH; Maron BJ
Circulation; 2001 Nov; 104(21):2517-24. PubMed ID: 11714644
[TBL] [Abstract][Full Text] [Related]
20. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
